Fluoropharma Medical Inc (FPMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,050 | -1,923 | -2,307 | -1,573 | -3,164 |
| Depreciation Amortization | 995 | 768 | 644 | 341 | 558 |
| Accounts payable and accrued liabilities | 323 | 230 | 223 | 121 | 617 |
| Other Working Capital | 1,532 | 1,161 | 1,287 | 322 | 579 |
| Other Operating Activity | -1,680 | -1,000 | -81 | 395 | -1,267 |
| Operating Cash Flow | $-880 | $-764 | $-234 | $-394 | $-2,677 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -1 | N/A | -7 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 36 |
| Investing Cash Flow | $-1 | $-1 | $-1 | $0 | $29 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 725 | 510 | 360 | 150 | 3,345 |
| Debt Repayment | -100 | N/A | N/A | N/A | -490 |
| Other Financing Activity | -10 | -8 | -7 | -6 | -169 |
| Financing Cash Flow | $615 | $502 | $353 | $144 | $2,686 |
| Beginning Cash Position | 291 | 291 | 291 | 291 | 252 |
| End Cash Position | 25 | 28 | 408 | 41 | 291 |
| Net Cash Flow | $-266 | $-263 | $118 | $-250 | $39 |
| Free Cash Flow | |||||
| Operating Cash Flow | -880 | -764 | -234 | -394 | -2,677 |
| Capital Expenditure | -1 | -1 | -1 | N/A | -7 |
| Free Cash Flow | -881 | -765 | -235 | -394 | -2,684 |